Ryan Maynard - 12 Sep 2022 Form 3 Insider Report for Cara Therapeutics, Inc. (CARA)

Role: Chief Financial Officer
Signature: /s/ Darren DeStefano, Attorney in Fact
Issuer symbol: CARA
Transactions as of: 12 Sep 2022
Transactions value $: $0
Form type: 3
Filing time: 14 Sep 2022, 16:40:36 UTC
Previous filing: 14 Jun 2022
Next filing: 03 Mar 2023
SEC: View on sec.gov

No securities are beneficially owned.

Remarks:

Exhibit List - Exhibit 24 - Power of Attorney No Table I or Table II securities beneficially owned